Does ENZALUTAMIDE Cause Dementia? 206 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 206 reports of Dementia have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.4% of all adverse event reports for ENZALUTAMIDE.
206
Reports of Dementia with ENZALUTAMIDE
0.4%
of all ENZALUTAMIDE reports
35
Deaths
45
Hospitalizations
How Dangerous Is Dementia From ENZALUTAMIDE?
Of the 206 reports, 35 (17.0%) resulted in death, 45 (21.8%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Dementia Listed in the Official Label?
Yes, Dementia is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Dementia?
APIXABAN (1,459)
PIMAVANSERIN (1,116)
CARBIDOPA\LEVODOPA (854)
LENALIDOMIDE (651)
SACUBITRIL\VALSARTAN (450)
INSULIN GLARGINE (438)
ADALIMUMAB (401)
INSULIN LISPRO (375)
RIVASTIGMINE (337)
TOFACITINIB (334)
Which ENZALUTAMIDE Alternatives Have Lower Dementia Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE